ABSTRACT
Myocarditis is a rare disease manifestation of acute Q fever caused by infection with Coxiella burnetii, an infectious Gram-negative proteobacteria. C. burnetii has a large animal reservoir and is often transmitted to humans during animal birth. Acute Q fever has a nonspecific disease presentation leading to delayed treatment and potentially worsened clinical outcomes. We describe a case of an otherwise healthy adult man with angina, ST elevations, and positive cardiac troponins-all findings suggestive of acute coronary syndrome. Cardiac catheterization revealed no significant coronary blockages or abnormalities. On echocardiography he was found to have heart failure with reduced ejection fraction. The patient's social history included several risk factors for Q fever. Serologic testing returned positive for anti-C. burnetii antibodies, and a diagnosis of acute Q fever myocarditis was made. The patient was appropriately treated with a course of doxycycline and clinically improved.
ABSTRACT
BACKGROUND: Tako-tsubo syndrome is a transient cardiomyopathy usually precipitated by an acute emotional or physiological stress. Our study objectives were to review and analyze the impact of emotional stress on clinical variables, echocardiographic characteristics, and short-term outcomes in patients with tako-tsubo syndrome. METHODS: Retrospective chart review. RESULTS: Eleven patients presented with tako-tsubo syndrome (1 man and 10 women) during the 8-year period (January 2000 to January 2008). The patients were split into 2 groups, defined by presenting either after emotional stress (6/11, 54.5%) or after idiopathic/physical stress (5/11, 45.5%). The mean age was 53.8 (12.6) years. The mean peak troponin T level was 0.54 ng/mL (range, 0.03-2.06 ng/mL), and the mean left ventricular end-diastolic pressure was 15.8 (8.1) mm Hg. Emotional stress was associated with younger age (P = 0.024), a lower left ventricular end-diastolic pressure (P < 0.05), more ST segment changes on electrocardiogram (66.7% vs 40%), and a higher ejection fraction (P = 0.012). The patients in the idiopathic/physical stress group required more frequent hemodynamic support. CONCLUSIONS: We conclude that clinical, echocardiographic, and outcome characteristics can differentiate tako-tsubo patients presenting with emotional stress from those with idiopathic/physical stress into 2 distinct clinical phenotypes. Clinicians should monitor idiopathic/physically stressed tako-tsubo patients carefully for hemodynamic compromise.
Subject(s)
Stress, Psychological/complications , Takotsubo Cardiomyopathy/etiology , Adult , Aged , Echocardiography , Electrocardiography , Female , Humans , Male , Middle Aged , Phenotype , Prognosis , Stress, Physiological , Syndrome , Takotsubo Cardiomyopathy/diagnostic imaging , Takotsubo Cardiomyopathy/physiopathology , Takotsubo Cardiomyopathy/psychology , Ventricular Dysfunction, Left/etiologySubject(s)
Carcinoma, Renal Cell/pathology , Heart Neoplasms/secondary , Heart Ventricles/pathology , Kidney Neoplasms/pathology , Tricuspid Valve/pathology , Carcinoma, Renal Cell/diagnosis , Echocardiography , Heart Neoplasms/diagnosis , Humans , Kidney Neoplasms/diagnosis , Male , Middle Aged , PrognosisABSTRACT
BACKGROUND: Diastolic dysfunction (DD) is common in elderly people. Myocardial fibrosis is a major determinant of diastolic function. Increased myocardial fibrosis has been observed with advancing age. We hypothesized that plasma levels of carboxy-terminal peptide of procollagen type I (PICP), a marker of fibrosis, is elevated in elderly subjects with DD compared to healthy control subjects. METHODS: PICP levels were measured in 29 elderly subjects with DD and 25 healthy control subjects. The relationship between PICP levels and age, gender, hypertension, and the presence of left ventricular hypertrophy were then assessed. RESULTS: PICP levels were significantly higher in elderly subjects with DD than in healthy control subjects (301.0 +/- 52.0 vs. 262.9 +/- 45.3 ng/mL; P = .006). PICP levels were higher in elderly with DD regardless of the presence of left ventricular hypertrophy. Additionally, PICP levels were not found to correlate with age. CONCLUSIONS: PICP levels are elevated in elderly people with DD. PICP may be a useful marker to determine the level of fibrotic activity in this population.
Subject(s)
Cardiomyopathies/blood , Hypertrophy, Left Ventricular/blood , Peptide Fragments/blood , Procollagen/blood , Aged , Aged, 80 and over , Biomarkers/blood , Diastole , Echocardiography , Female , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Diastolic dysfunction is common in the elderly. Increased myocardial fibrosis, a major determinant of diastolic function, has been observed with advancing age. Spironolactone prevents age-related increases in myocardial fibrosis in old normotensive rats. HYPOTHESIS: Spironolactone, via its antifibrotic activity, can improve diastolic function in the elderly with isolated diastolic dysfunction. METHODS: The study was a prospective, double-blind, randomized, placebo-controlled trial. Thirty elderly subjects between 60 and 85 years of age with isolated diastolic dysfunction and no contraindications for spironolactone were randomized to 25 mg/day of spironolactone or placebo for 4 months. Mitral E/A and deceleration time, plasma levels of carboxy-terminal of procollagen type I (PICP), and brain natriuretic peptide (BNP) were measured at baseline and at the end of 4 months. Plasma level of potassium was also monitored to prevent clinically significant hyperkalemia. RESULTS: There was no serious adverse event or clinically significant hyperkalemia in the spironolactone group. Compared with baseline values, spironolactone significantly improved mitral E/A ratio (0.71 +/- 0.08 vs. 0.84 +/- 0.19, p = 0.025) and deceleration time (285.5 +/- 73.1 vs. 230.0 +/- 54.7, p = 0.035). There were no significant differences in the magnitude of change in the levels of PICP and BNP between the two treatment groups. CONCLUSION: Spironolactone may improve diastolic function in the elderly.
Subject(s)
Diastole/drug effects , Mineralocorticoid Receptor Antagonists/therapeutic use , Spironolactone/therapeutic use , Aged , Aged, 80 and over , Blood Pressure/drug effects , Coronary Artery Disease/drug therapy , Coronary Artery Disease/metabolism , Coronary Artery Disease/physiopathology , Diastole/physiology , Double-Blind Method , Female , Fibrosis , Heart Rate/drug effects , Humans , Hypertension/drug therapy , Hypertension/metabolism , Hypertension/physiopathology , Hypertrophy, Left Ventricular/drug therapy , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Left Ventricular/physiopathology , Male , Middle Aged , Myocardium/metabolism , Myocardium/pathology , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Procollagen/blood , Prospective Studies , Time Factors , Treatment OutcomeSubject(s)
Coronary Artery Disease/diagnostic imaging , Heart Aneurysm/diagnostic imaging , Heart Aneurysm/etiology , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/etiology , Wounds, Gunshot/complications , Wounds, Gunshot/diagnostic imaging , Aged , Diagnosis, Differential , Exercise Test , Female , Humans , Organophosphorus Compounds , Organotechnetium Compounds , Radionuclide Imaging , RadiopharmaceuticalsABSTRACT
The true existence of a class effect in angiotensin-converting enzyme (ACE) inhibitors remains controversial. The present trial explored the effects of 2 ACE inhibitors after acute myocardial infarction and found no difference in endothelin-1 production but a greater increase in the production of total nitric oxide with quinapril than with enalapril.